SCHEMBL753643

SCHEMBL753643

Cc1ccc(-p2c3cc4c5sc6ccccc6c5p(-c5ccc(C)cc5)c4cc3c3sc4ccccc4c32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.39
▸ TNKS O95271 2/20 0.37
▸ TNKS2 Q9H2K2 2/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ L3MBTL1 Q9Y468 4/20 0.36
▸ MAOB P27338 1/20 0.36
▸ HCRTR1 O43613 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ RAB9A P51151 5/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ SMN1; SMN2 Q16637 5/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ ATM Q13315 1/20 0.35
▸ GPR3 P46089 1/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ TP53 P04637 2/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL753458 0.89 GPR3 (0.39) MAPTTNKSTNKS2ALDH1A1L3MBTL1
SCHEMBL752678 0.83 LIMK1 (0.40) TNKSTNKS2RAB9AMEN1KMT2A
SCHEMBL17951774 0.77 GPR3 (0.40) MAPTTNKSTNKS2ALDH1A1L3MBTL1
SCHEMBL755314 0.77 GPR3 (0.40) MAPTTNKSTNKS2ALDH1A1L3MBTL1
SCHEMBL753447 0.68 CYP2A6 (0.42) MAPTALDH1A1L3MBTL1LMNAPOLB
SCHEMBL10072557 0.67 MAPT (0.50) MAPTTNKSTNKS2ALDH1A1L3MBTL1
SCHEMBL22902217 0.66 MAPT (0.53) MAPTTNKSTNKS2ALDH1A1L3MBTL1
SCHEMBL23046392 0.66 TNKS (0.46) MAPTTNKSTNKS2ALDH1A1L3MBTL1
SCHEMBL12687983 0.66 TNKS (0.46) MAPTTNKSTNKS2ALDH1A1L3MBTL1
SCHEMBL26325344 0.66 TNKS (0.46) MAPTTNKSTNKS2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138355-B2 Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same TOSOH CORPORATION (JP) 2012-03-20 — — US disclosed
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME TOSOH CORPORATION (JP) 2009-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME AS3MT, TERT, TEAD1 MAPT 1194/4885TNKS 2910/4885TNKS2 2471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback